Published January 5, 2021 | Version v1

Response Rates to Anti–PD-1 Immunotherapy in Microsatellite-Stable Solid Tumors With 10 or More Mutations per Megabase

  • 1. Memorial Sloan Kettering Cancer Center

Description

This dataset has been used to analyze the association between tumor mutational burden and response to treatment in immunotherapy-treated patients with microsatellite-stable solid tumors. The dataset contains clinical and genomic data for 1,678 patients with 16 cancer types.

 

Files

Files (96.3 kB)

Name Size Download all
md5:1be79a159d7684a915a00f699794c1a8
96.3 kB Download